(The following press release from Mount Sinai Medical Center was received by 
e-mail. The sender verified the statement.) 
Newest Gift to Mount Sinai Caps Nearly $200 Million in Lifetime Support 
(New York – November 15, 2012) – Mount Sinai President and CEO Kenneth L. 
Davis, MD and Chairman of the Boards of Trustees Peter W. May announced today 
that the Mount Sinai School of Medicine has been renamed the Icahn School of 
Medicine at Mount Sinai in honor of Trustee Carl C. Icahn.  Mr. Icahn, whose 
latest gift is the largest in Mount Sinai’s history and among the biggest ever 
given to a medical school, signed the formal agreement Tuesday, November 13, 
2012 at his offices in midtown Manhattan. 
The new name was approved by the Boards of Trustees on September 24 in 
recognition of Mr. Icahn’s many years of dedicated service to the institution, 
his leadership in advancing medical science, and his nearly $200 million in 
lifetime giving to Mount Sinai. In addition, the Institute for Genomics and 
Multiscale Biology will be renamed the Icahn Genomics Institute.  
“Carl’s support enables our scientists and clinicians to continue pursuing 
groundbreaking discoveries. We are honored to bear the Icahn School of Medicine 
name as we revolutionize healthcare for Mount Sinai patients and for patients 
around the world,” said Dr. Davis. 
Mr. Icahn, one of America’s most prominent and influential investors, has been 
a member of the Boards of Trustees, and a Trustee of the School of Medicine 
since 2000. His gifts have been, and will continue to be, utilized for general 
medical research as well as specific research in the burgeoning field of 
genomics in order to improve the diagnosis and treatment of disease.  
Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of 
Medicine and Executive Vice President for Academic Affairs of The Mount Sinai 
Medical Center, said Mr. Icahn’s remarkable generosity would fund various 
research projects at the medical school’s numerous disease-focused and core 
technology-based institutes, including the newly named Icahn Institute for 
“Carl Icahn’s generosity has tremendously strengthened Mount Sinai’s capacity 
for innovation by allowing us flexibility and opportunistic creativity, two of 
the greatest assets for any innovative organization,” said Dr. Charney. “We are 
extremely grateful to Carl not only for his philanthropic support but also for 
his trust and confidence in Mount Sinai and the major role our institution will 
continue to play in transforming global health care.”  
Mr. Icahn’s previous contributions to Mount Sinai resulted in a 
state-of-the-art medical school research building on the Mount Sinai campus 
being named The Icahn Medical Institute. 
“I have been very impressed with Mount Sinai’s extraordinary achievements to 
date in scientific discovery, medical education, translational medicine and 
patient care,” said Mr. Icahn. “I am certain that my contributions to Mount 
Sinai will lead to significant medical breakthroughs in the diagnosis and 
treatment of disease that will dramatically improve and extend human life.”  
Mr. Icahn’s most recent giving to Mount Sinai has supported the Campaign for 
Mount Sinai, a $1 billion capital campaign that launched in 2008 and that 
recently surpassed its target, well in advance of its scheduled December 2013 
conclusion. “Carl Icahn has been a remarkable supporter of the capital 
campaign, and as a philanthropist, he is a game-changer for Mount Sinai,” said 
Peter May. “His gift helped us to surpass our original $1 billion goal and has 
given us the momentum we need to reach our new goal of $1.3 billion.” 
“No matter how you look at it, this is a historic time for Mount Sinai,” said 
Trustee James S. Tisch, who is chairman of the Campaign for Mount Sinai. 
“Carl’s gift caps off one of the most generous outpourings of institutional 
support I have ever seen. And with a year to go, every gift we receive ensures 
that more and more advances will be made in the research and clinical care that 
are the hallmarks of Mount Sinai.” 
About The Mount Sinai Medical Center   
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and 
Icahn School of Medicine at Mount Sinai. Established in 1968, the Icahn School 
of Medicine at Mount Sinai is one of the leading medical schools in the United 
States. The Icahn School of Medicine is noted for innovation in education, 
biomedical research, clinical care delivery, and local and global community 
service. It has more than 3,400 faculty members in 32 departments and 14 
research institutes, and ranks among the top 20 medical schools both in 
National Institutes of Health (NIH) funding and by U.S. News & World Report. 
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and 
quaternary-care teaching facility and one of the nation’s oldest, largest and 
most-respected voluntary hospitals. In 2012, U.S. News & World Report ranked 
The Mount Sinai Hospital 14th on its elite Honor Roll of the nation’s top 
hospitals based on reputation, safety, and other patient-care factors. Mount 
Sinai is one of just 12 integrated academic medical centers whose medical 
school ranks among the top 20 in NIH funding and by U.S. News & World Report 
and whose hospital is on the U.S. News & World Report Honor Roll.  Nearly 
60,000 people were treated at Mount Sinai as inpatients last year, and 
approximately 560,000 outpatient visits took place.  
For more information, visit 
Find Mount Sinai on:
Twitter @mountsinainyc
Mount Sinai Medical Center Newsroom 
(bjh) NY
Press spacebar to pause and continue. Press esc to stop.